MAGEA9 anticorps (Middle Region)
Aperçu rapide pour MAGEA9 anticorps (Middle Region) (ABIN927539)
Antigène
Voir toutes MAGEA9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- MAGEA9 antibody was raised in rabbit using the middle region of MAGEA9 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MAGEA9 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this MAGEA9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAGEA9 (Melanoma Antigen Family A, 9 (MAGEA9))
-
Autre désignation
- MAGEA9
-
Sujet
- MAGEA9 is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Synonyms: Polyclonal MAGEA9 antibody, Anti-MAGEA9 antibody, melanoma antigen family A, 9 antibody, MAGE9 antibody, MGC8421 antibody.
Antigène
-